These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 768997)

  • 1. [Current problems in effective-substance research. 9. Parameter-free methods for the structure-activity analysis].
    Gäbler E; Franke R; Oehme P
    Pharmazie; 1976; 31(1):1-14. PubMed ID: 768997
    [No Abstract]   [Full Text] [Related]  

  • 2. [MASCA-model of the biochemical-pharmacological drug research. Part 3: Structure-activity relationships and KANORA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Sep; 25(9):1355-6. PubMed ID: 1242657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MASCA-model of biochemical-pharmacological drug research. Part 6: Structure-activity relationship and bio-oscillations (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975; 25(12):1864-5. PubMed ID: 1243656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MASCA-model of the biochemical-pharmacological drug research/ part 4: Structure-activity relationships and MANOVA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Oct; 25(10):1475-6. PubMed ID: 1243023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MASCA-model of biochemical-pharmacological drug research/Part VIII: Examples (author's transl)].
    Mager PP
    Arzneimittelforschung; 1976 Feb; 26(2):185-7. PubMed ID: 7279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Nov; 25(11):1745. PubMed ID: 1243081
    [No Abstract]   [Full Text] [Related]  

  • 7. Principles and practice of Hansch analysis: a guide to structure-activity correlation for the medicinal chemist.
    Tute MS
    Adv Drug Res; 1971; 6():1-77. PubMed ID: 4946617
    [No Abstract]   [Full Text] [Related]  

  • 8. From empirical structure modifications to QSAR.
    Glasser AC
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):563-9. PubMed ID: 6513672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity correlations of 1,3-benzodioxole synergists.
    Tinland B; Decoret C; Badin J
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):131-4. PubMed ID: 4671997
    [No Abstract]   [Full Text] [Related]  

  • 11. Substituted cycloalkanol ethers of psychostimulant activity: studies on quantitative structure-activity relationships.
    Darvas F; Budai Z; Petöcz L; Kosóczky I
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):243-54. PubMed ID: 1197912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A quantitative structure-activity analysis based on quantum statistical derivations].
    Schwarz G; Barth A
    Pharmazie; 1975 Dec; 30(12):805-6. PubMed ID: 1219804
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current problems in drug research. I. Determination of the quantitative structure-activity relationships of biosubstances: theoretical principles, accomplishments, assumptions and present state].
    Franke R; Oehme P
    Pharmazie; 1973 Aug; 28(8):489-508. PubMed ID: 4131698
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticestode quinolinehydrazones.
    Pellerano C; Savini L; Berkoff CE; Thomas J; Actor P
    Farmaco Sci; 1975 Dec; 30(12):965-73. PubMed ID: 1204834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
    Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
    J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current problems of active substance research. 3. Structure-activity relationships of angiotensin II and analog].
    Piesche L; Hilse H; Scheer E
    Pharmazie; 1974 Apr; 29(4):233-51. PubMed ID: 4152658
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationship of isatin Mannich bases and hydrazones.
    Maysinger D; Movrin M
    Arzneimittelforschung; 1980; 30(11):1839-40. PubMed ID: 7192988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation using sequential trials methods.
    Cohen ME; Ralls SA
    J Dent Educ; 1986 Sep; 50(9):532-7. PubMed ID: 3462220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity correlations for acaricidal hydrazones.
    Tinland B
    Farmaco Sci; 1975 May; 30(5):423-4. PubMed ID: 1175768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.